Cite
APA Citation
Le Gouill, S., Wermke, M., Morschhauser, F., Lim, S., Salles, G., Kloos, I., de Burgat, V., Becquart, M., Paux, G., Kraus‐Berthier, L., Pennaforte, S., Stilgenbauer, S., Walewski, J., & Ribrag, V. (n.d.). a NEW BCL‐2 INHIBITOR (S55746/BCL201) AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMA: PRELIMINARY RESULTS OF THE FIRST‐IN‐HUMAN STUDY. Hematological oncology, 35, 47–48. http://access.bl.uk/ark:/81055/vdc_100047426577.0x000032